Formation of L-alloisoleucine in vivo: An L-[13C]isoleucine study in man

Pediatric Research

Volumn 47, Issue 2, 2000, Pages 271-277

  Schadewaldt, Peter ^a,b   Bodner Leidecker, Annette ^a   Hammen, Hans Werner ^a   Wendel, Udo ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOISOLEUCINE; CARBON 13; ISOLEUCINE;

ADULT; ARTICLE; BIOACCUMULATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; MAPLE SYRUP URINE DISEASE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSAMINATION;

EID: 0033973996     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200002000-00020     Document Type: Article

References (37)

1. McKusick VA 1994 Mendelian Inheritance in Man. 11th Ed. John Hopkins University Press, Baltimore.
2. Chuang DT, Shih VE 1995 Disorders of branched chain amino acid and keto acid metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill, New York, pp 1239-1277
3. Dancis J, Levitz M, Westall RG 1960 Maple syrup urine disease: branched-chain keto-aciduria. Pediatrics 25:72-79
4. Norton PM, Roitman E, Snyderman SE, Holt Jr LE 1962 A new finding in maple syrup urine disease. Lancet 1:26-27
5. Halpern B, Pollock GE 1970 The configuration of the alloisoleucine present in maple syrup urine disease plasma. Biochem Med 4:352-356
6. Jakobs C, Solem E, Ek J, Halvorsen K, Jellum E 1977 Investigation of the metabolic pattern in maple syrup urine disease by means of glass capillary gas chromatography and mass spectrometry. J Chromatogr 143:31-38
7. Mamer OA, Montgomery JA, Taguchi VY 1980 Origin of the two peaks for 2-keto-3-methylvaleric acid produced by the oxidation of the keto acids occurring in maple syrup urine disease. J Chromatogr 182:221-225
8. Schadewaldt P, Wendel U, Hammen H-W 1996 Determination of R-and S-3-methyl-2-oxopentanoate enantiomers in human plasma: suitable method for label enrichment analysis. J Chromatogr B 682:209-218
9. Mamer OA, Tjoa SS, Scriver CR, Klassen GA 1976 Demonstration of a new mammalian isoleucine catabolic pathway yielding an R series of metabolites. Biochem J 160:417-426
10. Batshaw ML, Brusilow S, Walser M 1976 Long-term management of a case of carbamyl phosphate synthetase deficiency using ketoanalogues and hydroxyanalogues of essential amino acids. Pediatrics 58:227-235
11. Meister A, White J 1951 Growth response of the rat to the keto analogues of leucine and isoleucine. J Biol Chem 191:211-216
12. Snyderman SE, Norton PM, Roitman E, Holt Jr LE 1964 Maple syrup urine disease with particular reference to dietotherapy. Pediatrics 34:454-462
13. Mamer OA, Reimer MLJ 1992 On the mechanism of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans. J Biol Chem 267:22141-22147
14. Matthews DE, Ben-Galim E, Haymond MW, Bier DM 1980 Alloisoleucine formation in maple syrup urine disease: isotopic evidence for the mechanism. Pediatr Res 14:854-857
15. Schadewaldt P, Wendel U, Hammen H-W 1995 Human branched-chain L-amino acid aminotransferase: activity and subcellular localization in cultured skin fibroblasts. Amino Acids 9:147-160
16. Meister A 1951 Studies on D-and L-α-keto-β-methylvaleric acids. J Biol Chem 190:269-276
17. Weinberg RB, Walser M 1977 Racemization and amination of the keto-analog of isoleucine in the intact dog. Biochem Med 17:164-172
18. Walser M, Sapir DG, Mitch WE, Chan W 1981 Effects of branched-chain ketoacids in normal subjects and patients. In: Walser M. Williamson JR (eds) Metabolism and Clinical Implication of Branched Chain Amino and Ketoacids. Elsevier. North Holland, pp 291-299
19. Schadewaldt P, Hammen H-W, Dalle-Feste C, Wendel U 1990 On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease. J Inher Metab Dis 13:137-150
20. Lam S 1986 Resolution of D-and L-amino acids after precolumn derivatization with 0-phthalaldehyde by mixed chelation with Cu(II)-L-proline. J Chromatogr 355:157-164
21. Schadewaldt P, Dalle-Feste C, Langenbeck U, Wendel U 1991 Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease. Pediatr Res 30:430-434
22. Bodner A, Hammen H-W, Renn W, Wendel U, Schadewaldt P 1997 Whole body branched-chain L-amino acid oxidation in overnight fasted human subjects. Isotopes Environ Health Stud 33:189-196
23. Wolfe RR 1992 Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. Wiley-Liss. New York. pp 230-232
24. Wendel U, Langenbeck U, Seakins JWT 1989 Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease. Pediatr Res 25:11-14
25. Dent CE, Westall RG 1961 Studies in maple syrup urine disease. Arch Dis Child 36:259-268
26. Funk MA, Lowry KR, Baker DH 1987 Utilization of the L-and DL-isomers of α-keto-β-methylvaleric acid by rats and comparative efficacy of the keto analogs of branched-chain amino acids provided as omithine, lysine and histidine salts. J Nutr 117:1550-1555
27. Greenstein JP, Levintow L, Baker CG, White J 1951 Preparation of the four stereoisomers of isoleucine. J Biol Chem 188:647-663
28. Goto M, Shinno H, Ichihara A 1977 Isoenzyme patterns of branched-chain amino acid transaminase in human tissues and tumors. Gann 68:663-667
29. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM 1998 A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 68:72-81
30. Crowell PL, Miller RH, Harper AE 1988 Measurement of plasma and tissue levels of branched-chain a-keto acids by gas-liquid chromatography. Methods Enzymol 166:39-46
31. Matuso Y, Yagi M, Walser M 1993 Arteriovenous differences and tissue concentrations of branched-chain ketoacids J Lab Clin Med 121:779-784
32. Askanazi J, Carpentier YA, Michelsen CB, Elwyn DH, Furst P, Kantrowitz LR, Gump FE, Kinney JM 1980 Muscle and plasma amino acids following injury: influence of intercurrent infections. Ann Surg 192:78-85
33. Chinkes D, Klein S, Zhang X-J, Wolfe RR 1996 Infusion of labeled K1C is more accurate than labeled leucine to determine human muscle protein synthesis. Am J Physiol 270:E67-E71
34. Schadewaldt P, Radeck W, Hammen H-W, Wendel U 1988 Transamination and oxidative decarboxylation rates of branched-chain 2-oxo acids in cultured human skin fibroblasts. Pediatr Res 23:40-44
35. Schadewaldt P, Radeck W, Hammen H-W, Staib W 1989 Transamination and oxidative decarboxylation of L-isoleucine, L-alloisoleucine and related 2-oxo acids in perfused rat hind limb muscle. Biochim Biophys Acta 992:115-123
36. Stalder K 1959 Über das Vorkommen von Äthylmalonsäure im Harn. Hoppe-Seyler's Z Physiol Chem 314:205-210
37. Schadewaldt P, Hammen H-W, Ott A-C, Wendel U 1999 Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis 22:706-722